<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CNU</journal-id>
<journal-id journal-id-type="hwp">spcnu</journal-id>
<journal-title>European Journal of Cardiovascular Nursing</journal-title>
<issn pub-type="ppub">1474-5151</issn>
<issn pub-type="epub">1873-1953</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1474515112443439</article-id>
<article-id pub-id-type="publisher-id">10.1177_1474515112443439</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>High nutritional risk is associated with worse health-related quality of life in patients with heart failure beyond sodium intake</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Son</surname><given-names>Youn-Jung</given-names></name>
<xref ref-type="aff" rid="aff1-1474515112443439">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Song</surname><given-names>Eun Kyeung</given-names></name>
<xref ref-type="aff" rid="aff2-1474515112443439">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1474515112443439"><label>1</label>Department of Nursing, College of Medicine, Soonchunhyang University, Cheonan, South Korea</aff>
<aff id="aff2-1474515112443439"><label>2</label>Department of Nursing, College of Medicine, University of Ulsan, Ulsan, South Korea</aff>
<author-notes>
<corresp id="corresp1-1474515112443439">Eun Kyeung Song, Department of Nursing, College of Medicine, University of Ulsan, Daehak-ro 93, Nam-gu, Ulsan, 680–749, South Korea Email: <email>gracesong@ulsan.ac.kr</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>12</volume>
<issue>2</issue>
<fpage>184</fpage>
<lpage>192</lpage>
<history>
<date date-type="received">
<day>1</day>
<month>9</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>7</day>
<month>3</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The European Society of Cardiology 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">European Society of Cardiology</copyright-holder>
</permissions>
<abstract>
<sec id="section1-1474515112443439">
<title>Background:</title>
<p>The most desirable outcome in heart failure (HF) management is to improve health-related quality of life (HRQoL) as a patient-centred health outcome. Nutrition is assumed to be important in HF management, whereas there is little evidence that nutritional risk affects HRQoL, except for sodium.</p>
</sec>
<sec id="section2-1474515112443439">
<title>Purpose:</title>
<p>We aimed to determine whether nutritional risk is associated with worse HRQoL after controlling for daily sodium intake. Methods: A total of 134 consecutive patients with HF [age 63±11 years, 35% female, 45% New York Heart Association (NYHA) class III/IV, ejection fraction (EF) 33±13%] completed the Nutrition Screening Initiative (NSI) to assess nutritional risk and a 24-h urine sodium excretion assessment to estimate daily sodium intake at baseline. The Minnesota Living with HF Questionnaire was used to evaluate HRQoL at baseline and 6 months later. Hierarchical linear regressions were used to determine whether nutritional risk predicted HRQoL at baseline and 6 months later.</p>
</sec>
<sec id="section3-1474515112443439">
<title>Results:</title>
<p>Seventy-eight (58.2%) patients had high nutritional risk as indicated by a total NSI score ≥6. Increased nutritional risk was independently associated with worse HRQoL at baseline and 6 months later (β=0.33, <italic>p</italic>&lt;0.001; β=0.35, <italic>p</italic>&lt;0.001, respectively), after controlling for age, gender, aetiology, body mass index, NYHA class, EF, total comorbidity score, prescribed medications, and daily sodium intake.</p>
</sec>
<sec id="section4-1474515112443439">
<title>Conclusion:</title>
<p>These findings show that higher nutritional risk beyond sodium intake affects worse HRQoL in patients with HF. Further work is required to provide specific dietary guidelines to improve health outcomes for patients with HF.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Dietary sodium</kwd>
<kwd>heart failure</kwd>
<kwd>nutritional status</kwd>
<kwd>quality of life</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section5-1474515112443439" sec-type="intro">
<title>Introduction</title>
<p>The ultimate goal of heart failure (HF) management is to improve health-related quality of life (HRQoL) of patients with HF. HRQoL reflects patients’ subjective perceptions about the multi-dimensional impact of their clinical condition and treatment on their daily lives including physical functioning and symptoms, emotional distress, and social activities.<sup><xref ref-type="bibr" rid="bibr1-1474515112443439">1</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr3-1474515112443439">3</xref></sup> Poor HRQoL has been shown to predict cardiac mortality or morbidity in HF patients.<sup><xref ref-type="bibr" rid="bibr4-1474515112443439">4</xref>,<xref ref-type="bibr" rid="bibr5-1474515112443439">5</xref></sup> In addition, HRQoL plays a more important role in determining health status than does objective physical status.<sup><xref ref-type="bibr" rid="bibr6-1474515112443439">6</xref>,<xref ref-type="bibr" rid="bibr7-1474515112443439">7</xref></sup> Most patients express a preference for better HRQoL compared to a longer life.<sup><xref ref-type="bibr" rid="bibr8-1474515112443439">8</xref>,<xref ref-type="bibr" rid="bibr9-1474515112443439">9</xref></sup> However, the role of HRQoL as a health outcome has received substantially less attention.</p>
<p>Nutrition is thought to be an important component of HF management. Indeed, approximately half of patients with HF suffer from malnutrition as seen in progressive weight loss, which is associated with higher rates of cardiac death.<sup><xref ref-type="bibr" rid="bibr10-1474515112443439">10</xref>,<xref ref-type="bibr" rid="bibr11-1474515112443439">11</xref></sup> Additionally, worsening HF symptoms, such as increased activity intolerance may, be more aggravated by poor nutrition.<sup><xref ref-type="bibr" rid="bibr12-1474515112443439">12</xref></sup> Loss of appetite, age-related changes in taste and smell, dietary sodium and caloric restriction, social isolation, and use of diuretics were identified to affect inadequate food intake, resulting in poor nutritional status.<sup><xref ref-type="bibr" rid="bibr12-1474515112443439">12</xref><xref ref-type="bibr" rid="bibr13-1474515112443439"/><xref ref-type="bibr" rid="bibr14-1474515112443439"/><xref ref-type="bibr" rid="bibr15-1474515112443439"/>–<xref ref-type="bibr" rid="bibr16-1474515112443439">16</xref></sup> Despite raising concerns about the poor nutritional status of HF patients, dietary recommendation in HF management has focused predominantly on a sodium-restricted diet.</p>
<p>Previous researchers reported the impact of a sodium-restricted diet on health outcomes including HRQoL,<sup><xref ref-type="bibr" rid="bibr17-1474515112443439">17</xref>,<xref ref-type="bibr" rid="bibr18-1474515112443439">18</xref></sup> while there has been little examination of the link between whole nutritional risk and HRQoL, except for sodium intake. Furthermore, nutrition-related research in patients with HF has been relatively limited and is insufficient to provide specific recommendations in clinical practice.<sup><xref ref-type="bibr" rid="bibr16-1474515112443439">16</xref>,<xref ref-type="bibr" rid="bibr19-1474515112443439">19</xref></sup> A few prior investigators<sup><xref ref-type="bibr" rid="bibr20-1474515112443439">20</xref>,<xref ref-type="bibr" rid="bibr21-1474515112443439">21</xref></sup> have reported that single or complex nutritional supplements were helpful in improving HRQoL through randomized controlled trials. However, these interventions were carried out for only a small number of HF patients. In addition, it has been known that a sodium-restricted diet is unpalatable and subsequently related to decreased appetite, leading to higher risk for poor nutritional intake.<sup><xref ref-type="bibr" rid="bibr14-1474515112443439">14</xref>,<xref ref-type="bibr" rid="bibr19-1474515112443439">19</xref>,<xref ref-type="bibr" rid="bibr22-1474515112443439">22</xref></sup> However, dietary sodium intake was not controlled for in most studies examining the effects of nutrient supplementation on HRQoL.<sup><xref ref-type="bibr" rid="bibr20-1474515112443439">20</xref>,<xref ref-type="bibr" rid="bibr21-1474515112443439">21</xref></sup> Also, HRQoL of patients with HF can be improved or impaired over time within 6 months without any intervention.<sup><xref ref-type="bibr" rid="bibr20-1474515112443439">20</xref>,<xref ref-type="bibr" rid="bibr23-1474515112443439">23</xref><xref ref-type="bibr" rid="bibr24-1474515112443439"/>–<xref ref-type="bibr" rid="bibr25-1474515112443439">25</xref></sup> Given the potential for change in HRQoL of patients with HF, it is essential to determine the impact of nutritional risk on HRQoL prospectively.</p>
<p>To address these gaps in knowledge, we aimed to: (1) compare nutritional risk-based differences in sample characteristics, and (2) prospectively determine whether nutritional risk is associated with worse HRQoL among community-dwelling patients with HF after controlling for daily sodium intake.</p>
</sec>
<sec id="section6-1474515112443439" sec-type="methods">
<title>Methods</title>
<sec id="section7-1474515112443439">
<title>Design and setting</title>
<p>A prospective, descriptive study design was used to determine the impact of nutritional risk on HRQoL beyond daily sodium intake among community-dwelling patients with HF. Patients were recruited from outpatient HF clinics in two regional tertiary medical centres located in Seoul, South Korea.</p>
</sec>
<sec id="section8-1474515112443439">
<title>Participants</title>
<p>Eligibility criteria for this study included: having a cardiologist-confirmed diagnosis of chronic HF for at least 2 years; being on a stable medication regimen including beta-blockers, diuretics, or angiotensin-converting enzyme (ACE) inhibitors for at least 6 months; having impaired left ventricular systolic function with left ventricular ejection fraction (LVEF) of less than 50%; and being able to read, write, and speak Korean.</p>
<p>Participants were excluded from this study if they had a contraindication to low sodium diet; an acute myocardial infarction 6 months before enrolment, any hospitalizations or emergency room visits in the 3 months prior to this study, any obvious cognitive impairment, defined as a diagnosis of cerebrovascular accident or dementia, a history of terminal illness such as cancer, severe hyperthyroidism, or hepatic or renal failure, or were undergoing cardiac transplant evaluation.</p>
<p>The required sample size for this study was calculated using a power analysis suggested by Erdfelder and colleagues.<sup><xref ref-type="bibr" rid="bibr26-1474515112443439">26</xref></sup> Considering a medium effect size (<italic>f</italic><sup>2</sup>=0.15), α of 0.05, 80% power (1–β), and a total of 12 independent variables, a sample size of at least 127 patients was required to obtain the G* power.<sup><xref ref-type="bibr" rid="bibr27-1474515112443439">27</xref></sup></p>
<p>A total of 164 patients were eligible for this study. Ten patients declined to participate and five patients withdrew. Nine patients did not complete the 24-h urine collection and six patients were lost to follow up. Thus, data from 134 patients were included in this study.</p>
</sec>
<sec id="section9-1474515112443439">
<title>Measures</title>
<sec id="section10-1474515112443439">
<title>Nutritional risk</title>
<p>Nutritional risk was evaluated by using the Nutrition Screening Initiative (NSI) checklist.<sup><xref ref-type="bibr" rid="bibr28-1474515112443439">28</xref></sup> This checklist was developed through a collaboration of the American Dietetic Association, the American Academy of Family Physicians, and the National Council on the Aging to screen community-dwelling older adults.<sup><xref ref-type="bibr" rid="bibr28-1474515112443439">28</xref></sup> It is a frequently used instrument designed to identify individuals whose diets are relatively low in nutrient intake compared to the recommended dietary allowance standards.<sup><xref ref-type="bibr" rid="bibr28-1474515112443439">28</xref></sup> The checklist consists of ten yes/no questions, each of which has a weight of 1 to 4. Cumulative scores can range from 0 to 21; higher scores indicate greater nutritional risk. The NSI checklist has been demonstrated to be valid for assessing nutritional risk in elderly people.<sup><xref ref-type="bibr" rid="bibr29-1474515112443439">29</xref>,<xref ref-type="bibr" rid="bibr30-1474515112443439">30</xref></sup> The recommended cut-offs are as follows: a total NSI score of 6 or higher indicates high nutritional risk, a total NSI score of 3–5 indicates moderate nutritional risk, and a total NSI score of 0–2 indicates good nutritional status. Prior investigators reported the reliabilities of the NSI checklist with Cronbach’s α ranging from 0.68 to 0.75 among Korean elderly.<sup><xref ref-type="bibr" rid="bibr31-1474515112443439">31</xref>,<xref ref-type="bibr" rid="bibr32-1474515112443439">32</xref></sup> In this study, the internal consistency of the NSI was demonstrated by a Cronbach’s α of 0.71.</p>
</sec>
<sec id="section11-1474515112443439">
<title>Dietary sodium intake</title>
<p>Dietary sodium intake per day was determined by measuring a 24-h urinary sodium excretion,<sup><xref ref-type="bibr" rid="bibr33-1474515112443439">33</xref></sup> which is considered to be an objective measure of daily sodium intake.<sup><xref ref-type="bibr" rid="bibr34-1474515112443439">34</xref></sup> At least 85% of dietary sodium intake is excreted in urine.<sup><xref ref-type="bibr" rid="bibr35-1474515112443439">35</xref>,<xref ref-type="bibr" rid="bibr36-1474515112443439">36</xref></sup> A 24-h urinary sodium excretion has been correlated with dietary sodium intake as estimated by a food intake<sup><xref ref-type="bibr" rid="bibr37-1474515112443439">37</xref></sup> and dietary records review.<sup><xref ref-type="bibr" rid="bibr38-1474515112443439">38</xref>,<xref ref-type="bibr" rid="bibr39-1474515112443439">39</xref></sup> Urine sodium excretion in millimoles was converted to milligrams (mg=mmol×22.99). If patients had a 24-h urine volume of less than 500 ml or excretion of creatinine &lt;10mg/kg/day, those cases were considered incomplete,<sup><xref ref-type="bibr" rid="bibr40-1474515112443439">40</xref></sup> and were excluded from the data analysis.</p>
</sec>
<sec id="section12-1474515112443439">
<title>Health-related quality of life (HRQoL)</title>
<p>The Minnesota Living with Heart Failure Questionnaire (LHFQ)<sup><xref ref-type="bibr" rid="bibr3-1474515112443439">3</xref></sup> was used to assess HRQoL at baseline and 6 months later. This instrument was developed specially to measure HF patients’ perception of how much their illness and its treatment affects perceived quality of life.<sup><xref ref-type="bibr" rid="bibr3-1474515112443439">3</xref></sup> This instrument is the most commonly used disease-specific measure in HF research and clinical practice. The LHFQ consists of 21 items rated on a scale from 0 (no effect) to 5 (very much). Item ratings are summated for a total score that can range from 0 to 105. Higher scores reflect worse HRQoL. The LHFQ contains two subscales: physical and emotional. The physical subscale consists of eight items (difficulties in daily activities, resting, sleeping, and impact of HF symptoms) and the emotional subscale consists of five items (emotional distress and cognitive problems). The other eight items are used only in the total score (difficulties in social activities, sexual activity, eating, hospitalization, medical costs, and side effects from medications). Several investigators have examined the psychometric properties of the LHFQ in patients with HF and found strong reliabilities of the total, physical, and emotional scales with Cronbach’s α ranging from 0.88 to 0.93.<sup><xref ref-type="bibr" rid="bibr3-1474515112443439">3</xref>,<xref ref-type="bibr" rid="bibr23-1474515112443439">23</xref>,<xref ref-type="bibr" rid="bibr41-1474515112443439">41</xref>,<xref ref-type="bibr" rid="bibr42-1474515112443439">42</xref></sup> In this study, the internal consistency of the total, physical, and emotional scales was demonstrated by a Cronbach’s α of 0.92, 0.91, and 0.90, respectively.</p>
</sec>
<sec id="section13-1474515112443439">
<title>Other risk factors</title>
<p>Other risk factors including age, gender, presence of spouse, body mass index (BMI), New York Heart Association (NYHA) class, aetiology of HF, LVEF, comorbidity level as measured by the Charlson’s comorbidity index,<sup><xref ref-type="bibr" rid="bibr43-1474515112443439">43</xref></sup> and prescribed medications were collected through patient interviews and review of medical records. The Charlson’s comorbidity index<sup><xref ref-type="bibr" rid="bibr43-1474515112443439">43</xref></sup> was designed to classify comorbid conditions that might change the risk for mortality.</p>
</sec>
</sec>
<sec id="section14-1474515112443439">
<title>Data collection</title>
<p>The research proposal and protocol were approved by the Institutional Review Board at each enrolment site prior to data collection. After potential subjects meeting the inclusion criteria were identified by the primary investigator, a trained research assistant contacted eligible patients to inquire about willingness to have the primary investigator contact them by telephone to explain the purposes and procedures for the study. Once verbal consent was obtained from eligible patients, the primary investigator called to make an appointment for a visit to an outpatient clinic. Written informed consent was subsequently obtained from patients in an outpatient clinic, prior to data collection.</p>
<p>A trained research assistant provided patients with a urine collection container and a sheet to record the time and volume of each urination, and provided instructions on the procedures for urine collection. Patients collected all of their urine over a specified 24-h period. After completion of the 24-h urine collection, patients brought their urine containers to outpatient HF clinics and then completed a series of questionnaires. A trained research assistant reviewed the questionnaires and the 24-h urine collection sheets to ensure completeness. If patients forgot to save urine or lost any amount of urine, those cases were considered incomplete and were not included in the final analysis. At 6 months after baseline assessment, patients were provided the LHFQ to assess HRQoL in an outpatient clinic.</p>
</sec>
<sec id="section15-1474515112443439">
<title>Statistical analysis</title>
<p>SPSS for Windows 18.0 was used for data analysis in this study. Descriptive statistics were used to describe the patient characteristics. The independent <italic>t</italic>-test and chi-squared tests were used to compare differences in sample characteristics between patients with higher nutritional intake and those with lower nutritional intake. Hierarchical multiple linear regression was used to determine whether nutritional risk was independently associated with worse HRQoL at baseline and 6 months later after controlling for other risk factors and daily sodium intake. Other risk factors including age, gender, presence of spouse, BMI, HF aetiology, LVEF, comorbidity level, and prescribed medications were found to be related to impaired HRQoL in HF patients in previous studies.<sup><xref ref-type="bibr" rid="bibr44-1474515112443439">44</xref><xref ref-type="bibr" rid="bibr45-1474515112443439"/><xref ref-type="bibr" rid="bibr46-1474515112443439"/><xref ref-type="bibr" rid="bibr47-1474515112443439"/>–<xref ref-type="bibr" rid="bibr48-1474515112443439">48</xref></sup></p>
<p>A total LHFQ score at baseline and 6 months later were almost normally distributed. Skewness of a total LHFQ score at baseline and 6 months later were 0.30 and 0.31, respectively, while kurtoses of a total LHFQ score at baseline and 6 months later were −0.70 and −0.59. To control for possible multicollinearity issues, a collinearity analysis including tolerance value, variance inflation factor (VIF) and condition index was performed before conducting the multiple linear regression. The multicollinearity assumption was not violated in this study with the Durbin Watson statistic of 1.896, the tolerance value of 0.756–0.946 (&gt;0.5) and VIF of 1.057–1.323 (close to 1–2). Adjusted <italic>R</italic><sup>2</sup> was calculated to explain how well nutritional risk predicted HRQoL at baseline and 6 months later in HF patients after controlling for other risk factors and daily sodium intake. The <italic>p</italic>-value of less than 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="section16-1474515112443439" sec-type="results">
<title>Results</title>
<sec id="section17-1474515112443439">
<title>Sample characteristics</title>
<p>Sample characteristics are shown in <xref ref-type="table" rid="table1-1474515112443439">Table 1</xref>. The patients were primarily male with an age range of 45–97 years. About 70% of the patients were of normal weight or overweight in accordance with the obesity cut-off points for East Asians established by the World Health Organization.<sup><xref ref-type="bibr" rid="bibr49-1474515112443439">49</xref></sup> The majority of patients were in NYHA functional class II or III. Seventy percent of patients had hypertension and one-third had diabetes mellitus as comorbidities. Over the half of the patients lived with a spouse. Most patients were taking prescribed beta-blockers, diuretics, and ACE inhibitors. Fifty-four percent of patients had a 24-h urinary sodium excretion that indicated a daily sodium intake of greater than 3 g. Seventy-eight patients (58.2%) had high nutritional risk as indicated by a total NSI score equal to or greater than 6. Overall, participants had lower scores in HRQoL at baseline with a range of 0–96.</p>
<table-wrap id="table1-1474515112443439" position="float">
<label>Table 1.</label>
<caption>
<p>Patient characteristics</p>
</caption>
<graphic alternate-form-of="table1-1474515112443439" xlink:href="10.1177_1474515112443439-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Characteristic</th>
<th align="left">Population (<italic>n</italic>=134)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age (years)</td>
<td>63±11</td>
</tr>
<tr>
<td colspan="2">Gender</td>
</tr>
<tr>
<td> Male</td>
<td>87 (64.9)</td>
</tr>
<tr>
<td> Female</td>
<td>47 (35.1)</td>
</tr>
<tr>
<td>Spouse</td>
<td/>
</tr>
<tr>
<td> With spouse</td>
<td>73 (54.5)</td>
</tr>
<tr>
<td> Without spouse</td>
<td>61 (45.5)</td>
</tr>
<tr>
<td>Body mass index (kg/m<sup>2</sup>)</td>
<td>23.7±3.5</td>
</tr>
<tr>
<td> Underweight (&lt;18.5)</td>
<td>10 (07.5)</td>
</tr>
<tr>
<td> Normal weight (18.5–22.9)</td>
<td>44 (32.8)</td>
</tr>
<tr>
<td> Overweight (23.0–27.4)</td>
<td>53 (39.6)</td>
</tr>
<tr>
<td> Obese (&gt;27.5)</td>
<td>27 (20.1)</td>
</tr>
<tr>
<td colspan="2">NYHA class</td>
</tr>
<tr>
<td> I</td>
<td>14 (10.4)</td>
</tr>
<tr>
<td> II</td>
<td>60 (44.8)</td>
</tr>
<tr>
<td> III</td>
<td>44 (32.8)</td>
</tr>
<tr>
<td> IV</td>
<td>16 (11.9)</td>
</tr>
<tr>
<td colspan="2">Aetiology of heart failure</td>
</tr>
<tr>
<td> Non-ischaemic heart disease</td>
<td>71 (53.0)</td>
</tr>
<tr>
<td> Ischaemic heart disease</td>
<td>63 (47.0)</td>
</tr>
<tr>
<td>Left ventricular ejection fraction (%)</td>
<td>33.0±13.1</td>
</tr>
<tr>
<td>Total comorbidity score</td>
<td>3.0±1.7</td>
</tr>
<tr>
<td> Hypertension</td>
<td>94 (70.1)</td>
</tr>
<tr>
<td> Diabetes mellitus</td>
<td>42 (31.3)</td>
</tr>
<tr>
<td> Atrial fibrillation</td>
<td>60 (44.8)</td>
</tr>
<tr>
<td colspan="2">Medication</td>
</tr>
<tr>
<td> ACE inhibitors</td>
<td>97 (72.4)</td>
</tr>
<tr>
<td> Angiotension II receptor blocker</td>
<td>22 (16.4)</td>
</tr>
<tr>
<td> Digoxin</td>
<td>32 (23.9)</td>
</tr>
<tr>
<td> Beta-blocker</td>
<td>120 (89.6)</td>
</tr>
<tr>
<td> Diuretics</td>
<td>96 (71.6)</td>
</tr>
<tr>
<td>Nutritional risk (in total NSI score)</td>
<td>6.64±3.34</td>
</tr>
<tr>
<td> Good nutritional status (0–2)</td>
<td>9 (6.7)</td>
</tr>
<tr>
<td> Moderate nutritional risk (3–5)</td>
<td>47 (35.1)</td>
</tr>
<tr>
<td> High nutritional risk (≥6)</td>
<td>78 (58.2)</td>
</tr>
<tr>
<td>Daily sodium intake (24-h UNa, mg/day)</td>
<td>3357±1614</td>
</tr>
<tr>
<td> &lt;3000 mg/day</td>
<td>62 (46.3)</td>
</tr>
<tr>
<td> ≥3000 mg/day</td>
<td>72 (53.7)</td>
</tr>
<tr>
<td>HRQoL at baseline (in total LHFQ score)</td>
<td>37.8±22.6</td>
</tr>
<tr>
<td> Physical subscale</td>
<td>17.6±10.4</td>
</tr>
<tr>
<td> Emotional subscale</td>
<td>6.8±7.0</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1474515112443439">
<p>Values are mean±SD or <italic>n</italic> (%). ACE, angiotensin-converting enzyme; HRQoL, health-related quality of life; LHFQ, the Minnesota Living with HF Questionnaire; NSI, Nutrition Screening Initiative; NYHA, New York Heart Association; 24-h UNa, 24-h urinary sodium excretion.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section18-1474515112443439">
<title>Nutritional risk-based differences</title>
<p>Only nine patients (6.7%) had good nutritional status as indicated by a total NSI score of 0–2 (<xref ref-type="table" rid="table1-1474515112443439">Table 1</xref>). Patients were divided into two groups: those with a total NSI score of 6 or higher indicating people at higher nutritional risk and those with a total NSI score of 0–5 for people at lower nutritional risk.</p>
<p><xref ref-type="table" rid="table2-1474515112443439">Table 2</xref> shows the nutritional risk-based differences in sample characteristics, and HRQoL at baseline and 6 months later. In bivariate analysis, patients with higher nutritional risk had a higher total comorbidity score than those with lower nutritional risk (<italic>p</italic>=0.038). There was a significant difference in the use of diuretics between patients with higher and lower nutritional risk (<italic>p</italic>=0.047). HRQoL as assessed by the LHFQ was lower in patients who had higher nutritional risk than in patients with lower nutritional risk at baseline and 6 months later (<italic>p</italic>&lt;0.001, <italic>p</italic>=0.003, respectively). However, there were no significant differences in total LHFQ scores between at baseline and at 6 months in lower and higher nutritional risk group, respectively (<italic>t</italic>=1.881, <italic>p</italic>=0.065; <italic>t</italic>=0.331, <italic>p</italic>=0.741, respectively), and between the two groups (<italic>t</italic>=1.039, <italic>p</italic>=0.310). There were no nutritional risk-based differences for any other patient characteristics.</p>
<table-wrap id="table2-1474515112443439" position="float">
<label>Table 2.</label>
<caption>
<p>Nutritional risk-based differences</p>
</caption>
<graphic alternate-form-of="table2-1474515112443439" xlink:href="10.1177_1474515112443439-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Characteristic</th>
<th align="left">Lower nutritional risk (<italic>n</italic>=56)</th>
<th align="left">Higher nutritional risk (<italic>n</italic>=78)</th>
<th align="left"><italic>t</italic> or χ<sup>2</sup></th>
<th align="left"><italic>p</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td>Age(years)</td>
<td>64±10</td>
<td>62±12</td>
<td>0.67</td>
<td>0.415</td>
</tr>
<tr>
<td colspan="5">Gender</td>
</tr>
<tr>
<td> Male</td>
<td>38 (67.9)</td>
<td>49 (62.8)</td>
<td>0.36</td>
<td>0.547</td>
</tr>
<tr>
<td> Female</td>
<td>18 (32.1)</td>
<td>29 (37.2)</td>
<td/>
<td/>
</tr>
<tr>
<td colspan="5">Spouse</td>
</tr>
<tr>
<td> With spouse</td>
<td>35 (62.5)</td>
<td>38 (48.7)</td>
<td>2.50</td>
<td>0.114</td>
</tr>
<tr>
<td> Without spouse</td>
<td>21 (37.5)</td>
<td>40 (51.3)</td>
<td/>
<td/>
</tr>
<tr>
<td>Body mass index (kg/m<sup>2</sup>)</td>
<td>24.3±3.3</td>
<td>23.2±3.6</td>
<td>3.75</td>
<td>0.055</td>
</tr>
<tr>
<td colspan="5">NYHA class</td>
</tr>
<tr>
<td> I/II</td>
<td>36 (64.3)</td>
<td>38 (48.7)</td>
<td>3.20</td>
<td>0.074</td>
</tr>
<tr>
<td> III/IV</td>
<td>20 (35.7)</td>
<td>40 (51.3)</td>
<td/>
<td/>
</tr>
<tr>
<td colspan="5">Aetiology</td>
</tr>
<tr>
<td> Non-ischaemic heart disease</td>
<td>32 (57.1)</td>
<td>39 (50.0)</td>
<td>0.67</td>
<td>0.414</td>
</tr>
<tr>
<td> Ischaemic heart disease</td>
<td>24 (42.9)</td>
<td>39 (50.0)</td>
<td/>
<td/>
</tr>
<tr>
<td>Left ventricular ejection fraction (%)</td>
<td>34±14</td>
<td>32±12</td>
<td>1.22</td>
<td>0.271</td>
</tr>
<tr>
<td>Total comorbidity score</td>
<td>2.7±1.3</td>
<td>3.3±2.0</td>
<td>4.38</td>
<td>0.038</td>
</tr>
<tr>
<td colspan="5">Medication</td>
</tr>
<tr>
<td> ACE inhibitors</td>
<td>44 (78.6)</td>
<td>53 (67.9)</td>
<td>1.84</td>
<td>0.175</td>
</tr>
<tr>
<td> ARB II</td>
<td>7 (12.5)</td>
<td>15 (19.2)</td>
<td>1.08</td>
<td>0.300</td>
</tr>
<tr>
<td> Digoxin</td>
<td>14 (25.0)</td>
<td>18 (23.1)</td>
<td>0.07</td>
<td>0.797</td>
</tr>
<tr>
<td> Diuretics</td>
<td>35 (62.5)</td>
<td>61(78.2)</td>
<td>3.96</td>
<td>0.047</td>
</tr>
<tr>
<td> Beta-blocker</td>
<td>51 (91.1)</td>
<td>69 (88.5)</td>
<td>0.24</td>
<td>0.626</td>
</tr>
<tr>
<td>Daily sodium intake (24-h UNa, mg/day)</td>
<td>3484±1832</td>
<td>3266±1442</td>
<td>0.60</td>
<td>0.442</td>
</tr>
<tr>
<td> &lt;3000 mg/day</td>
<td>24 (42.9)</td>
<td>38 (48.7)</td>
<td>0.45</td>
<td>0.502</td>
</tr>
<tr>
<td> ≥3000 mg/day</td>
<td>32 (57.1)</td>
<td>40 (51.3)</td>
<td/>
<td/>
</tr>
<tr>
<td>HRQoL at baseline (total LHFQ score)</td>
<td>28.7±21.8</td>
<td>44.3±21.0</td>
<td>17.60</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td> Physical subscale</td>
<td>13.5±9.8</td>
<td>20.6±9.8</td>
<td>16.86</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td> Emotional subscale</td>
<td>4.6±5.9</td>
<td>8.4±7.2</td>
<td>10.59</td>
<td>0.001</td>
</tr>
<tr>
<td>HRQoL at 6-month (total LHFQ score)</td>
<td>32.5±21.8</td>
<td>45.1±24.4</td>
<td>9.37</td>
<td>0.003</td>
</tr>
<tr>
<td> Physical subscale</td>
<td>14.7±10.5</td>
<td>21.3±10.7</td>
<td>10.87</td>
<td>0.001</td>
</tr>
<tr>
<td> Emotional subscale</td>
<td>6.4±6.8</td>
<td>10.5±7.5</td>
<td>8.76</td>
<td>0.004</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1474515112443439">
<p>Values are mean±SD or <italic>n</italic> (%). ACE, angiotensin-converting enzyme; ARB II, angiotensin II receptor blocker; HRQoL, health-related quality of life; LHFQ, the Minnesota Living with HF Questionnaire; NSI, Nutrition Screening Initiative; NYHA, New York Heart Association; 24-h UNa, 24-h urinary sodium excretion.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section19-1474515112443439">
<title>Nutritional risk and HRQoL at baseline and at 6-month follow-up period</title>
<p>Higher nutritional risk as indicated by an increase in total NSI score was independently associated with worse HRQoL in patients with HF (β=0.33, <italic>p</italic>&lt;0.001), after adjusting for age, gender, aetiology of HF, BMI, NYHA class, LVEF, total comorbidity scores, use of beta-blockers and diuretics, and daily sodium intake (<xref ref-type="table" rid="table3-1474515112443439">Table 3</xref>). Nutritional risk was an independent predictor (<italic>t</italic>=3.92, <italic>p</italic>&lt;0.001) of worse HRQoL and explained 9% of the variance in worse HRQoL in the hierarchical multiple linear regression.</p>
<table-wrap id="table3-1474515112443439" position="float">
<label>Table 3.</label>
<caption>
<p>Hierarchical linear regression analysis for health-related quality of life at baseline and at 6 months</p>
</caption>
<graphic alternate-form-of="table3-1474515112443439" xlink:href="10.1177_1474515112443439-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Variables</th>
<th align="left" colspan="6">HRQoL at baseline<hr/></th>
<th align="left" colspan="6">HRQoL at 6 months<hr/></th>
</tr>
<tr>
<th/>
<th align="left" colspan="3">Step 1<hr/></th>
<th align="left" colspan="3">Step 2<hr/></th>
<th align="left" colspan="3">Step 1<hr/></th>
<th align="left" colspan="3">Step 2<hr/></th>
</tr>
<tr>
<th/>
<th align="left">Standardized β</th>
<th align="left"><italic>t</italic></th>
<th align="left"><italic>p</italic></th>
<th align="left">Standardized β</th>
<th align="left"><italic>t</italic></th>
<th align="left"><italic>p</italic></th>
<th align="left">Standardized β</th>
<th align="left"><italic>t</italic></th>
<th align="left"><italic>p</italic></th>
<th align="left">Standardized β</th>
<th align="left"><italic>t</italic></th>
<th align="left"><italic>p</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td>Age</td>
<td>−0.22</td>
<td>−2.51</td>
<td>0.013</td>
<td>−0.13</td>
<td>−1.57</td>
<td>0.118</td>
<td>−0.21</td>
<td>−2.34</td>
<td>0.021</td>
<td>−0.12</td>
<td>−1.38</td>
<td>0.170</td>
</tr>
<tr>
<td>Female</td>
<td>−0.02</td>
<td>−0.27</td>
<td>0.791</td>
<td>−0.00</td>
<td>−0.02</td>
<td>0.983</td>
<td>−0.05</td>
<td>−0.53</td>
<td>0.595</td>
<td>−0.03</td>
<td>−0.30</td>
<td>0.766</td>
</tr>
<tr>
<td>Without spouse</td>
<td>0.03</td>
<td>0.30</td>
<td>0.768</td>
<td>0.07</td>
<td>0.85</td>
<td>0.395</td>
<td>0.03</td>
<td>0.35</td>
<td>0.729</td>
<td>0.08</td>
<td>0.92</td>
<td>0.359</td>
</tr>
<tr>
<td>Body mass index</td>
<td>0.07</td>
<td>0.77</td>
<td>0.442</td>
<td>0.13</td>
<td>1.49</td>
<td>0.138</td>
<td>0.11</td>
<td>1.21</td>
<td>0.230</td>
<td>0.18</td>
<td>1.97</td>
<td>0.052</td>
</tr>
<tr>
<td>NYHA class III/IV</td>
<td>0.25</td>
<td>2.96</td>
<td>0.004</td>
<td>0.22</td>
<td>2.70</td>
<td>0.008</td>
<td>0.13</td>
<td>1.46</td>
<td>0.148</td>
<td>0.09</td>
<td>1.11</td>
<td>0.270</td>
</tr>
<tr>
<td>IHD</td>
<td>−0.11</td>
<td>−1.16</td>
<td>0.249</td>
<td>−0.12</td>
<td>−1.37</td>
<td>0.173</td>
<td>−0.04</td>
<td>−0.41</td>
<td>0.686</td>
<td>−0.05</td>
<td>−0.58</td>
<td>0.563</td>
</tr>
<tr>
<td>LVEF</td>
<td>−0.07</td>
<td>−0.73</td>
<td>0.468</td>
<td>−0.10</td>
<td>−1.20</td>
<td>0.233</td>
<td>0.02</td>
<td>0.20</td>
<td>0.843</td>
<td>−0.02</td>
<td>−0.23</td>
<td>0.815</td>
</tr>
<tr>
<td>Total comorbidity score</td>
<td>0.18</td>
<td>1.99</td>
<td>0.049</td>
<td>0.10</td>
<td>1.15</td>
<td>0.252</td>
<td>0.21</td>
<td>2.20</td>
<td>0.030</td>
<td>0.12</td>
<td>1.35</td>
<td>0.178</td>
</tr>
<tr>
<td>Beta-blocker</td>
<td>−0.07</td>
<td>−0.86</td>
<td>0.393</td>
<td>−0.10</td>
<td>−1.22</td>
<td>0.224</td>
<td>−0.08</td>
<td>−0.89</td>
<td>0.374</td>
<td>−0.10</td>
<td>−1.27</td>
<td>0.207</td>
</tr>
<tr>
<td>Diuretics</td>
<td>0.01</td>
<td>0.13</td>
<td>0.897</td>
<td>−0.02</td>
<td>−0.29</td>
<td>0.772</td>
<td>0.00</td>
<td>0.01</td>
<td>0.990</td>
<td>−0.04</td>
<td>−0.42</td>
<td>0.673</td>
</tr>
<tr>
<td>Daily sodium intake</td>
<td>−0.03</td>
<td>−0.31</td>
<td>0.760</td>
<td>−0.03</td>
<td>−0.37</td>
<td>0.709</td>
<td>0.04</td>
<td>0.47</td>
<td>0.636</td>
<td>0.04</td>
<td>0.45</td>
<td>0.652</td>
</tr>
<tr>
<td>Nutritional risk</td>
<td/>
<td/>
<td/>
<td>0.33</td>
<td>3.94</td>
<td>&lt;0.001</td>
<td/>
<td/>
<td/>
<td>0.35</td>
<td>4.02</td>
<td>&lt;0.001</td>
</tr>
<tr>
<td colspan="13">Overall</td>
</tr>
<tr>
<td> Adjusted <italic>R</italic><sup>2</sup></td>
<td>0.19</td>
<td/>
<td/>
<td>0.28</td>
<td/>
<td/>
<td>0.14</td>
<td/>
<td/>
<td>0.24</td>
<td/>
<td/>
</tr>
<tr>
<td> Δ in adjusted <italic>R</italic><sup>2</sup></td>
<td>0.19</td>
<td/>
<td/>
<td>0.09</td>
<td/>
<td/>
<td>0.14</td>
<td/>
<td/>
<td>0.10</td>
<td/>
<td/>
</tr>
<tr>
<td> <italic>p</italic>-value</td>
<td>0.005</td>
<td/>
<td/>
<td>&lt;0.001</td>
<td/>
<td/>
<td>0.035</td>
<td/>
<td/>
<td>&lt;0.001</td>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1474515112443439">
<p>HRQoL, health-related quality of life; IHD, ischaemic heart disease; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>At the 6-month follow-up period, a greater total NSI score indicating increased nutritional risk independently predicted worse HRQoL in patients with HF (β=0.35, <italic>p</italic>&lt;0.001), after controlling for the previously described risk factors and daily sodium intake (<xref ref-type="table" rid="table3-1474515112443439">Table 3</xref>). Nutritional risk was an independent predictor (<italic>t</italic>=4.02, <italic>p</italic>&lt;0.001) of worse HRQoL and explained 10% of the variance in worse HRQoL in the hierarchical multiple linear regression.</p>
</sec>
</sec>
<sec id="section20-1474515112443439" sec-type="discussion">
<title>Discussion</title>
<p>This is the first prospective study to show that nutritional risk affects adverse health outcomes beyond sodium intake in patients with HF. This study demonstrated that HF patients with higher nutritional risk were independently at greater risk for having worse HRQoL after adjusting for other risk factors and daily sodium intake. These findings may give healthcare providers clinically relevant evidence essential for improving patient education. Clinicians caring for patients with HF need to be aware of the importance of nutrition self-care beyond daily sodium intake. In general, little additional information on dietary assessment, evaluation, or instruction for patients with HF has been included in the current guidelines, aside from the dietary sodium restriction.<sup><xref ref-type="bibr" rid="bibr50-1474515112443439">50</xref><xref ref-type="bibr" rid="bibr51-1474515112443439"/>–<xref ref-type="bibr" rid="bibr52-1474515112443439">52</xref></sup> In addition, previous studies have demonstrated that patients with HF paid less attention to dietary advice and had some difficulty in understanding the importance of nutrition self-care for their quality of life.<sup><xref ref-type="bibr" rid="bibr53-1474515112443439">53</xref>,<xref ref-type="bibr" rid="bibr54-1474515112443439">54</xref></sup> Accordingly, both the importance of nutrition self-care and the impact of nutritional risk on HRQoL should be emphasized in patient education. Early detection of patients at risk for malnutrition is recommended using the NSI checklist at patient bedsides to promote adequate nutritional intake.</p>
<p>In our study, approximately 60% of patients were at high nutritional risk and the average total NSI score was 6.64±3.34. The percentage of patients at high nutritional risk in our study is much higher than has been reported in the elderly population, among whom nutritional risk ranged from 5 to 44%.<sup><xref ref-type="bibr" rid="bibr28-1474515112443439">28</xref>,<xref ref-type="bibr" rid="bibr30-1474515112443439">30</xref>,<xref ref-type="bibr" rid="bibr55-1474515112443439">55</xref></sup> This result reinforces our knowledge that patients with HF are suffering from poor nutrition. Prior investigators<sup><xref ref-type="bibr" rid="bibr13-1474515112443439">13</xref>,<xref ref-type="bibr" rid="bibr15-1474515112443439">15</xref>,<xref ref-type="bibr" rid="bibr56-1474515112443439">56</xref></sup> reported that HF patients did not have adequate macronutrients to meet the required energy. Lemon et al.<sup><xref ref-type="bibr" rid="bibr57-1474515112443439">57</xref></sup> and Arcand et al.<sup><xref ref-type="bibr" rid="bibr58-1474515112443439">58</xref></sup> reported that the majority of patients with HF had deficiencies in micronutrients such as calcium, magnesium, and potassium. Only one randomized controlled trial showed the effect of a combination of micronutrient supplementation on quality of life in elderly patients with HF.<sup><xref ref-type="bibr" rid="bibr20-1474515112443439">20</xref></sup> Given these limited findings from previous studies, there is little evidence as to which of these nutrients is essential or in what doses they should be given in clinical implications. Thus, it does suggest the need for further investigation to provide standard dietary recommendations which may lead to improved health outcomes for patients with HF. In addition to standard guidelines, nursing interventions targeting adequate nutritional intake for patients with HF are required to be built on knowledge of individual eating habits and dietary patterns as well as utilization of their own resources.</p>
<p>In bivariate analyses, greater portion of patients in the group with higher nutritional risk were taking diuretics than in the group with lower nutritional risk (78.2% vs. 62.5%). Several studies have suggested a possible explanation for the relationship between diuretics and nutritional status of HF patients.<sup><xref ref-type="bibr" rid="bibr16-1474515112443439">16</xref>,<xref ref-type="bibr" rid="bibr59-1474515112443439">59</xref>,<xref ref-type="bibr" rid="bibr60-1474515112443439">60</xref></sup> Diuretics can alter the sense of taste, reduce appetite, and aggravate dryness of the mouth in combination with beta-blockers, which poses a risk of inadequate food intake. In addition, diuretics decrease absorption of nutrients resulting in muscle wasting or cardiac cachexia. Therefore, it is recommended that HF patients taking diuretics with beta-blockers should be closely watched and their nutritional status should be continuously monitored in clinical settings.</p>
<p>Previous investigators<sup><xref ref-type="bibr" rid="bibr16-1474515112443439">16</xref>,<xref ref-type="bibr" rid="bibr59-1474515112443439">59</xref>,<xref ref-type="bibr" rid="bibr60-1474515112443439">60</xref></sup> suggested that neurohormonal activation or increased proinflammatory cytokines could be linked to a biological mechanism connecting poor nutritional status and adverse health outcomes in patients with HF. Catapano and colleagues<sup><xref ref-type="bibr" rid="bibr61-1474515112443439">61</xref></sup> showed that HF patients with inadequate food intake had higher levels of proinflammatory cytokines. Additionally, prior researchers have reported that depressive symptoms are more prevalent in elderly people who have inadequate food intake,<sup><xref ref-type="bibr" rid="bibr62-1474515112443439">62</xref><xref ref-type="bibr" rid="bibr63-1474515112443439"/>–<xref ref-type="bibr" rid="bibr64-1474515112443439">64</xref></sup> and depressive symptoms and micronutrient deficiency had a synergistic effect on cardiac event-free survival in patients with HF.<sup><xref ref-type="bibr" rid="bibr65-1474515112443439">65</xref></sup> These findings suggested that depressive symptoms play a role in the link between poor nutritional status and adverse health outcomes. Likewise, future studies are needed to determine the biological and psychological pathways which may explain how poor nutritional status affects adverse health outcomes.</p>
<p>HRQoL at 6 months from baseline seemed to be worse compared with that at baseline in our study, but there were no significant changes in HRQoL at 6 months from baseline in both lower and higher nutritional risk groups. Moreover, change of HRQoL within 6 months was no significant between two groups. Patients with HF in our study had a relatively high level of nutritional risk at baseline, which could explain why both groups experienced no significant change in HRQoL within 6 months. The mean level of nutritional risk score was 6.6, indicating high nutritional risk. The high level of nutritional risk in our sample likely resulted in the inability to detect a significant change of HRQoL over time within 6 months between the two groups.</p>
<p>This study has a number of limitations. Although a prospective study design was used in this study, caution should be taken in drawing certain causal relationships between nutritional risk and HRQoL. The 24-h urine collection for estimating daily sodium intake was conducted one time at baseline, reflecting daily sodium intake for that specified 24-h period only. Also, the NSI checklist used in this study is not a diagnostic instrument measuring actual nutrient intake. Thus, it is important to keep in mind that being at risk of malnutrition may be different from actually being malnourished. Findings from our study should be interpreted in light of these limitations. Further investigation is required to determine the impact of nutritional risk on survival or rehospitalization as clinician-centred health outcomes through randomized controlled trials and longitudinal prospective study designs.</p>
</sec>
<sec id="section21-1474515112443439" sec-type="conclusions">
<title>Conclusions</title>
<p>Our data demonstrated that HF patients who are at higher risk of malnutrition had a worse HRQoL at baseline and 6 months later after controlling for daily sodium intake. This is the first study to determine the relationships between nutritional risk and HRQoL as a patient-centred health outcome in Korean patients with HF. In addition to close monitoring for nutritional risk at bedsides, patient education should focus on the link between nutrition self-care and HRQoL, as well as the importance of nutrition self-care. Further investigation is required to develop evidence-based nursing interventions for adequate nutrition intake and provide specific dietary guidelines which may lead to improved health outcomes for patients with HF.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This work was supported by the Research Fund of University of Ulsan (No. 2012-0141).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1474515112443439">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Scott</surname><given-names>LD</given-names></name>
</person-group>. <article-title>Caregiving and care receiving among a technologically dependent heart failure population</article-title>. <source>Adv Nurs Sci</source> <year>2000</year>; <volume>23</volume>(<issue>2</issue>): <fpage>82</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr2-1474515112443439">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Westlake</surname><given-names>C</given-names></name>
<name><surname>Dracup</surname><given-names>K</given-names></name>
<name><surname>Creaser</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Correlates of health-related quality of life in patients with heart failure</article-title>. <source>Heart Lung</source> <year>2002</year>; <volume>31</volume>(<issue>2</issue>): <fpage>85</fpage>–<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr3-1474515112443439">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rector</surname><given-names>TS</given-names></name>
<name><surname>Cohn</surname><given-names>JN</given-names></name>
</person-group>. <article-title>Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group</article-title>. <source>Am Heart J</source> <year>1992</year>; <volume>124</volume>(<issue>4</issue>): <fpage>1017</fpage>–<lpage>1025</lpage>.</citation>
</ref>
<ref id="bibr4-1474515112443439">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moser</surname><given-names>DK</given-names></name>
<name><surname>Yamokoski</surname><given-names>L</given-names></name>
<name><surname>Sun</surname><given-names>JL</given-names></name><etal/>
</person-group>. <article-title>Improvement in health-related quality of life after hospitalization predicts event-free survival in patients with advanced heart failure</article-title>. <source>J Card Fail</source> <year>2009</year>; <volume>15</volume>(<issue>9</issue>): <fpage>763</fpage>–<lpage>769</lpage>.</citation>
</ref>
<ref id="bibr5-1474515112443439">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mommersteeg</surname><given-names>PM</given-names></name>
<name><surname>Denollet</surname><given-names>J</given-names></name>
<name><surname>Spertus</surname><given-names>JA</given-names></name><etal/>
</person-group>. <article-title>Health status as a risk factor in cardiovascular disease: a systematic review of current evidence</article-title>. <source>Am Heart J</source> <year>2009</year>; <volume>157</volume>(<issue>2</issue>): <fpage>208</fpage>–<lpage>218</lpage>.</citation>
</ref>
<ref id="bibr6-1474515112443439">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arnold</surname><given-names>R</given-names></name>
<name><surname>Ranchor</surname><given-names>AV</given-names></name>
<name><surname>Koeter</surname><given-names>GH</given-names></name><etal/>
</person-group>. <article-title>Consequences of chronic obstructive pulmonary disease and chronic heart failure: the relationship between objective and subjective health</article-title>. <source>Soc Sci Med</source> <year>2005</year>; <volume>61</volume>(<issue>10</issue>): 2<fpage>144</fpage>–<lpage>2154</lpage>.</citation>
</ref>
<ref id="bibr7-1474515112443439">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaplan</surname><given-names>RM</given-names></name>
<name><surname>Ries</surname><given-names>AL</given-names></name>
</person-group>. <article-title>Quality of life: concept and definition</article-title>. <source>COPD</source>. <year>2007</year>; <volume>4</volume>(<issue>3</issue>): <fpage>263</fpage>–<lpage>271</lpage>.</citation>
</ref>
<ref id="bibr8-1474515112443439">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Spertus</surname><given-names>JA</given-names></name>
</person-group>. <article-title>Evolving applications for patient-centered health status measures</article-title>. <source>Circulation</source> <year>2008</year>; <volume>118</volume>(<issue>20</issue>): <fpage>2103</fpage>–<lpage>2110</lpage>.</citation>
</ref>
<ref id="bibr9-1474515112443439">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lewis</surname><given-names>EF</given-names></name>
<name><surname>Johnson</surname><given-names>PA</given-names></name>
<name><surname>Johnson</surname><given-names>W</given-names></name><etal/>
</person-group>. <article-title>Preferences for quality of life or survival expressed by patients with heart failure</article-title>. <source>J Heart Lung Transplant</source> <year>2001</year>; <volume>20</volume>(<issue>9</issue>): <fpage>1016</fpage>–<lpage>1024</lpage>.</citation>
</ref>
<ref id="bibr10-1474515112443439">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Anker</surname><given-names>SD</given-names></name>
<name><surname>Negassa</surname><given-names>A</given-names></name>
<name><surname>Coats</surname><given-names>AJ</given-names></name><etal/>
</person-group>. <article-title>Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study</article-title>. <source>Lancet</source> <year>2003</year>; <volume>361</volume>(<issue>9363</issue>): <fpage>1077</fpage>–<lpage>1083</lpage>.</citation>
</ref>
<ref id="bibr11-1474515112443439">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pocock</surname><given-names>SJ</given-names></name>
<name><surname>McMurray</surname><given-names>JJ</given-names></name>
<name><surname>Dobson</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme</article-title>. <source>Eur Heart J</source> <year>2008</year>; <volume>29</volume>(<issue>21</issue>): <fpage>2641</fpage>–<lpage>2650</lpage>.</citation>
</ref>
<ref id="bibr12-1474515112443439">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Witte</surname><given-names>KK</given-names></name>
<name><surname>Clark</surname><given-names>AL</given-names></name>
<name><surname>Cleland</surname><given-names>JG</given-names></name>
</person-group>. <article-title>Chronic heart failure and micronutrients</article-title>. <source>J Am Coll Cardiol</source> <year>2001</year>; <volume>37</volume>(<issue>7</issue>): <fpage>1765</fpage>–<lpage>1774</lpage>.</citation>
</ref>
<ref id="bibr13-1474515112443439">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aquilani</surname><given-names>R</given-names></name>
<name><surname>Opasich</surname><given-names>C</given-names></name>
<name><surname>Verri</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Is nutritional intake adequate in chronic heart failure patients?</article-title> <source>J Am Coll Cardiol</source> <year>2003</year>; <volume>42</volume>(<issue>7</issue>): <fpage>1218</fpage>–<lpage>1223</lpage>.</citation>
</ref>
<ref id="bibr14-1474515112443439">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lennie</surname><given-names>TA</given-names></name>
<name><surname>Moser</surname><given-names>DK</given-names></name>
<name><surname>Heo</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Factors influencing food intake in patients with heart failure: a comparison with healthy elders</article-title>. <source>J Cardiovasc Nurs</source> <year>2006</year>; <volume>21</volume>(<issue>2</issue>): <fpage>123</fpage>–<lpage>129</lpage>.</citation>
</ref>
<ref id="bibr15-1474515112443439">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grossniklaus</surname><given-names>DA</given-names></name>
<name><surname>O’Brien</surname><given-names>MC</given-names></name>
<name><surname>Clark</surname><given-names>PC</given-names></name><etal/>
</person-group>. <article-title>Nutrient intake in heart failure patients</article-title>. <source>J Cardiovasc Nurs</source> <year>2008</year>; <volume>23</volume>(<issue>4</issue>): <fpage>357</fpage>–<lpage>363</lpage>.</citation>
</ref>
<ref id="bibr16-1474515112443439">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jacobsson</surname><given-names>A</given-names></name>
<name><surname>Pihl-Lindgren</surname><given-names>E</given-names></name>
<name><surname>Fridlund</surname><given-names>B</given-names></name>
</person-group>. <article-title>Malnutrition in patients suffering from chronic heart failure; the nurse’s care</article-title>. <source>Eur J Heart Fail</source> <year>2001</year>; <volume>3</volume>(<issue>4</issue>): <fpage>449</fpage>–<lpage>456</lpage>.</citation>
</ref>
<ref id="bibr17-1474515112443439">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Welsh</surname><given-names>D</given-names></name>
<name><surname>Marcinek</surname><given-names>R</given-names></name>
<name><surname>Abshire</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Theory-based intervention increases low sodium diet adherence in patients with heart failure</article-title>. <source>Circulation</source> <year>2009</year>; <volume>120</volume>: <fpage>5514</fpage>.</citation>
</ref>
<ref id="bibr18-1474515112443439">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuehneman</surname><given-names>T</given-names></name>
<name><surname>Saulsbury</surname><given-names>D</given-names></name>
<name><surname>Splett</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Demonstrating the impact of nutrition intervention in a heart failure program</article-title>. <source>J Am Diet Assoc</source> <year>2002</year>; <volume>102</volume>(<issue>12</issue>): <fpage>1790</fpage>–<lpage>1794</lpage>.</citation>
</ref>
<ref id="bibr19-1474515112443439">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lennie</surname><given-names>TA</given-names></name>
</person-group>. <article-title>Nutrition self-care in heart failure: state of the science</article-title>. <source>J Cardiovasc Nurs</source> <year>2008</year>; <volume>23</volume>(<issue>3</issue>): <fpage>197</fpage>–<lpage>204</lpage>.</citation>
</ref>
<ref id="bibr20-1474515112443439">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Witte</surname><given-names>KK</given-names></name>
<name><surname>Nikitin</surname><given-names>NP</given-names></name>
<name><surname>Parker</surname><given-names>AC</given-names></name><etal/>
</person-group>. <article-title>The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure</article-title>. <source>Eur Heart J</source> <year>2005</year>; <volume>26</volume>(<issue>21</issue>): <fpage>2238</fpage>–<lpage>2244</lpage>.</citation>
</ref>
<ref id="bibr21-1474515112443439">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rozentryt</surname><given-names>P</given-names></name>
<name><surname>von Haehling</surname><given-names>S</given-names></name>
<name><surname>Lainscak</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study</article-title>. <source>J Cachex Sarcopenia Muscle</source> <year>2010</year>; <volume>1</volume>(<issue>1</issue>): <fpage>35</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr22-1474515112443439">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bentley</surname><given-names>B</given-names></name>
<name><surname>De Jong</surname><given-names>MJ</given-names></name>
<name><surname>Moser</surname><given-names>DK</given-names></name><etal/>
</person-group>. <article-title>Factors related to nonadherence to low sodium diet recommendations in heart failure patients</article-title>. <source>Eur J Cardiovasc Nurs</source> <year>2005</year>; <volume>4</volume>(<issue>4</issue>): <fpage>331</fpage>–<lpage>436</lpage>.</citation>
</ref>
<ref id="bibr23-1474515112443439">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Riegel</surname><given-names>B</given-names></name>
<name><surname>Moser</surname><given-names>DK</given-names></name>
<name><surname>Glaser</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>The Minnesota Living With Heart Failure Questionnaire: sensitivity to differences and responsiveness to intervention intensity in a clinical population</article-title>. <source>Nurs Res</source> <year>2002</year>; <volume>51</volume>(<issue>4</issue>): <fpage>209</fpage>–<lpage>218</lpage>.</citation>
</ref>
<ref id="bibr24-1474515112443439">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rector</surname><given-names>TS</given-names></name>
<name><surname>Tschumperlin</surname><given-names>LK</given-names></name>
<name><surname>Kubo</surname><given-names>SH</given-names></name><etal/>
</person-group>. <article-title>Use of the Living With Heart Failure questionnaire to ascertain patients’ perspectives on improvement in quality of life versus risk of drug-induced death</article-title>. <source>J Card Fail</source> <year>1995</year>; <volume>1</volume>(<issue>3</issue>): <fpage>201</fpage>–<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr25-1474515112443439">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holland</surname><given-names>R</given-names></name>
<name><surname>Rechel</surname><given-names>B</given-names></name>
<name><surname>Stepien</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Patients’ self-assessed functional status in heart failure by New York Heart Association class: a prognostic predictor of hospitalizations, quality of life and death</article-title>. <source>J Card Fail</source> <year>2010</year>; <volume>16</volume>(<issue>2</issue>): <fpage>150</fpage>–<lpage>156</lpage>.</citation>
</ref>
<ref id="bibr26-1474515112443439">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Erdfelder</surname><given-names>E</given-names></name>
<name><surname>Faul</surname><given-names>F</given-names></name>
<name><surname>Buchner</surname><given-names>A</given-names></name>
</person-group>. <article-title>GPOWER: a general power analysis program</article-title>. <source>Behav Res Meth Instrum Comput</source> <year>1996</year>; <volume>28</volume>: <fpage>1</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr27-1474515112443439">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Faul</surname><given-names>F</given-names></name>
<name><surname>Erdfelder</surname><given-names>E</given-names></name>
<name><surname>Lang</surname><given-names>AG</given-names></name><etal/>
</person-group>. <article-title>G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences</article-title>. <source>Behav Res Methods</source> <year>2007</year>; <volume>39</volume>(<issue>2</issue>): <fpage>175</fpage>–<lpage>191</lpage>.</citation>
</ref>
<ref id="bibr28-1474515112443439">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Posner</surname><given-names>BM</given-names></name>
<name><surname>Jette</surname><given-names>AM</given-names></name>
<name><surname>Smith</surname><given-names>KW</given-names></name><etal/>
</person-group>. <article-title>Nutrition and health risks in the elderly: the nutrition screening initiative</article-title>. <source>Am J Public Health</source> <year>1993</year>; <volume>83</volume>(<issue>7</issue>): <fpage>972</fpage>–<lpage>978</lpage>.</citation>
</ref>
<ref id="bibr29-1474515112443439">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barrocas</surname><given-names>A</given-names></name>
<name><surname>Bistrian</surname><given-names>BR</given-names></name>
<name><surname>Blackburn</surname><given-names>GL</given-names></name><etal/>
</person-group>. <article-title>Appropriate and effective use of the NSI checklist and screens. An update on caring for the elderly by preventing malnutrition</article-title>. <source>J Am Diet Assoc</source> <year>1995</year>; <volume>95</volume>(<issue>6</issue>): <fpage>647</fpage>–<lpage>648</lpage>.</citation>
</ref>
<ref id="bibr30-1474515112443439">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>HJ</given-names></name>
<name><surname>Lee</surname><given-names>KS</given-names></name>
<name><surname>Eom</surname><given-names>JS</given-names></name><etal/>
</person-group>. <article-title>Relation between nutritional risk and metabolic syndrome in the elderly</article-title>. <source>Arch Gerontol Geriatr</source> <year>2011</year>; <volume>52</volume>(<issue>1</issue>): <fpage>e19</fpage>–<lpage>e22</lpage>.</citation>
</ref>
<ref id="bibr31-1474515112443439">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jung</surname><given-names>YM</given-names></name>
<name><surname>Kim</surname><given-names>JH</given-names></name>
</person-group>. <article-title>[Comparison of cognitive levels, nutritional status, depression in the elderly according to living situations]</article-title>. <source>Taehan Kanho Hakhoe Chi</source> <year>2004</year>; <volume>34</volume>(<issue>3</issue>): <fpage>495</fpage>–<lpage>503</lpage>.</citation>
</ref>
<ref id="bibr32-1474515112443439">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>CG</given-names></name>
</person-group>. [<article-title>The relationship of family support, health perception, nutritional status and depression in elders</article-title>]. <source>J Korean Gerontolog Nurs</source> <year>2007</year>; <volume>9</volume>(<issue>1</issue>): <fpage>14</fpage>–<lpage>21</lpage>.</citation>
</ref>
<ref id="bibr33-1474515112443439">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Espeland</surname><given-names>MA</given-names></name>
<name><surname>Kumanyika</surname><given-names>S</given-names></name>
<name><surname>Wilson</surname><given-names>AC</given-names></name><etal/>
</person-group>. <article-title>Statistical issues in analyzing 24-hour dietary recall and 24-hour urine collection data for sodium and potassium intakes</article-title>. <source>Am J Epidemiol</source> <year>2001</year>; <volume>153</volume>(<issue>10</issue>): <fpage>996</fpage>–<lpage>1006</lpage>.</citation>
</ref>
<ref id="bibr34-1474515112443439">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beich</surname><given-names>KR</given-names></name>
<name><surname>Yancy</surname><given-names>C</given-names></name>
</person-group>. <article-title>The heart failure and sodium restriction controversy: challenging conventional practice</article-title>. <source>Nutr Clin Pract</source> <year>2008</year>; <volume>23</volume>(<issue>5</issue>): <fpage>477</fpage>–<lpage>486</lpage>.</citation>
</ref>
<ref id="bibr35-1474515112443439">
<label>35.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Bates</surname><given-names>CJ</given-names></name>
<name><surname>Thurnham</surname><given-names>DI</given-names></name>
<name><surname>Bingham</surname><given-names>SA</given-names></name>
</person-group>. <article-title>Biochemical markers of nutrient intakes</article-title>. In: <source>Design concepts in nutritional epidemiology</source>. <publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>, <year>1997</year>, pp.<fpage>170</fpage>–<lpage>240</lpage>.</citation>
</ref>
<ref id="bibr36-1474515112443439">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pietinen</surname><given-names>P</given-names></name>
</person-group>. <article-title>Estimating sodium intake from food consumption data</article-title>. <source>Ann Nutr Metab</source> <year>1982</year>; <volume>26</volume>(<issue>2</issue>): <fpage>90</fpage>–<lpage>99</lpage>.</citation>
</ref>
<ref id="bibr37-1474515112443439">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shin</surname><given-names>E</given-names></name>
<name><surname>Lee</surname><given-names>H</given-names></name>
<name><surname>Lee</surname><given-names>J</given-names></name><etal/>
</person-group>. [<article-title>Estimation of sodium intake of adult female by 24-hour urine analysis, dietary records and dish frequency questionnaire (DFQ 55)</article-title>] <source>Korean J Nutr</source> <year>2010</year>; <volume>43</volume>(<issue>1</issue>): <fpage>79</fpage>–<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr38-1474515112443439">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McKeown</surname><given-names>NM</given-names></name>
<name><surname>Day</surname><given-names>NE</given-names></name>
<name><surname>Welch</surname><given-names>AA</given-names></name><etal/>
</person-group>. <article-title>Use of biological markers to validate self-reported dietary intake in a random sample of the European Prospective Investigation into Cancer United Kingdom Norfolk cohort</article-title>. <source>Am J Clin Nutr</source> <year>2001</year>; <volume>74</volume>(<issue>2</issue>): <fpage>188</fpage>–<lpage>196</lpage>.</citation>
</ref>
<ref id="bibr39-1474515112443439">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arcand</surname><given-names>J</given-names></name>
<name><surname>Floras</surname><given-names>JS</given-names></name>
<name><surname>Azevedo</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>Evaluation of 2 methods for sodium intake assessment in cardiac patients with and without heart failure: the confounding effect of loop diuretics</article-title>. <source>Am J Clin Nutr</source> <year>2011</year>; <volume>93</volume>(<issue>3</issue>): <fpage>535</fpage>–<lpage>541</lpage>.</citation>
</ref>
<ref id="bibr40-1474515112443439">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wilson</surname><given-names>DK</given-names></name>
<name><surname>Sica</surname><given-names>DA</given-names></name>
<name><surname>Miller</surname><given-names>SB</given-names></name>
</person-group>. <article-title>Effects of potassium on blood pressure in salt-sensitive and salt-resistant black adolescents</article-title>. <source>Hypertension</source> <year>1999</year>; <volume>34</volume>(<issue>2</issue>): <fpage>181</fpage>–<lpage>186</lpage>.</citation>
</ref>
<ref id="bibr41-1474515112443439">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heo</surname><given-names>S</given-names></name>
<name><surname>Moser</surname><given-names>DK</given-names></name>
<name><surname>Riegel</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Testing the psychometric properties of the Minnesota Living with Heart Failure questionnaire</article-title>. <source>Nurs Res</source> <year>2005</year>; <volume>54</volume>(<issue>4</issue>): <fpage>265</fpage>–<lpage>272</lpage>.</citation>
</ref>
<ref id="bibr42-1474515112443439">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bennet</surname><given-names>SJ</given-names></name>
<name><surname>Oldridge</surname><given-names>NB</given-names></name>
<name><surname>Eckert</surname><given-names>GJ</given-names></name><etal/>
</person-group>. <article-title>Discriminant properties of commonly used quality of life measures in heart failure</article-title>. <source>Qual Life Res</source> <year>2002</year>; <volume>11</volume>(<issue>4</issue>): <fpage>349</fpage>–<lpage>359</lpage>.</citation>
</ref>
<ref id="bibr43-1474515112443439">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Charlson</surname><given-names>ME</given-names></name>
<name><surname>Pompei</surname><given-names>P</given-names></name>
<name><surname>Ales</surname><given-names>KL</given-names></name><etal/>
</person-group>. <article-title>A new method of classifying prognostic comorbidity in longitudinal studies: development and validation</article-title>. <source>J Chronic Dis</source> <year>1987</year>; <volume>40</volume>(<issue>5</issue>): <fpage>373</fpage>–<lpage>383</lpage>.</citation>
</ref>
<ref id="bibr44-1474515112443439">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Faller</surname><given-names>H</given-names></name>
<name><surname>Stork</surname><given-names>S</given-names></name>
<name><surname>Schuler</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Depression and disease severity as predictors of health-related quality of life in patients with chronic heart failure – a structural equation modeling approach</article-title>. <source>J Card Fail</source> <year>2009</year>; <volume>15</volume>(<issue>4</issue>): <fpage>286</fpage>–<lpage>292</lpage>, <fpage>e2</fpage>.</citation>
</ref>
<ref id="bibr45-1474515112443439">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Franzen</surname><given-names>K</given-names></name>
<name><surname>Saveman</surname><given-names>BI</given-names></name>
<name><surname>Blomqvist</surname><given-names>K</given-names></name>
</person-group>. <article-title>Predictors for health related quality of life in persons 65 years or older with chronic heart failure</article-title>. <source>Eur J Cardiovasc Nurs</source> <year>2007</year>; <volume>6</volume>(<issue>2</issue>): <fpage>112</fpage>–<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr46-1474515112443439">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gott</surname><given-names>M</given-names></name>
<name><surname>Barnes</surname><given-names>S</given-names></name>
<name><surname>Parker</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Predictors of the quality of life of older people with heart failure recruited from primary care</article-title>. <source>Age Ageing</source> <year>2006</year>; <volume>35</volume>(<issue>2</issue>): <fpage>172</fpage>–<lpage>177</lpage>.</citation>
</ref>
<ref id="bibr47-1474515112443439">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grady</surname><given-names>KL</given-names></name>
<name><surname>Jalowiec</surname><given-names>A</given-names></name>
<name><surname>White-Williams</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Predictors of quality of life in patients with advanced heart failure awaiting transplantation</article-title>. <source>J Heart Lung Transplant</source> <year>1995</year>; <volume>14</volume>(<issue>1</issue> Pt 1): <fpage>2</fpage>–<lpage>10</lpage>.</citation>
</ref>
<ref id="bibr48-1474515112443439">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Volz</surname><given-names>A</given-names></name>
<name><surname>Schmid</surname><given-names>JP</given-names></name>
<name><surname>Zwahlen</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Predictors of readmission and health related quality of life in patients with chronic heart failure: a comparison of different psychosocial aspects</article-title>. <source>J Behav Med</source> <year>2011</year>; <volume>34</volume>(<issue>1</issue>): <fpage>13</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr49-1474515112443439">
<label>49.</label>
<citation citation-type="journal">
<collab>WHO Expert Consultation</collab>. <article-title>Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies</article-title>. <source>Lancet</source> <year>2004</year>; <volume>363</volume>(<issue>9403</issue>): <fpage>157</fpage>–<lpage>163</lpage>.</citation>
</ref>
<ref id="bibr50-1474515112443439">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hunt</surname><given-names>SA</given-names></name>
<name><surname>Abraham</surname><given-names>WT</given-names></name>
<name><surname>Chin</surname><given-names>MH</given-names></name><etal/>
</person-group>. <article-title>2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation</article-title>. <source>Circulation</source> <year>2009</year>; <volume>119</volume>(<issue>14</issue>): <fpage>e391</fpage>–<lpage>e479</lpage>.</citation>
</ref>
<ref id="bibr51-1474515112443439">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lindenfeld</surname><given-names>J</given-names></name>
<name><surname>Albert</surname><given-names>NM</given-names></name>
<name><surname>Boehmer</surname><given-names>JP</given-names></name><etal/>
</person-group>. <article-title>HFSA 2010 Comprehensive Heart Failure Practice Guideline</article-title>. <source>J Card Fail</source> <year>2010</year>; <volume>16</volume>(<issue>6</issue>): <fpage>e1</fpage>–<lpage>e194</lpage>.</citation>
</ref>
<ref id="bibr52-1474515112443439">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dickstein</surname><given-names>K</given-names></name>
<name><surname>Cohen-Solal</surname><given-names>A</given-names></name>
<name><surname>Filippatos</surname><given-names>G</given-names></name><etal/>
</person-group>. <article-title>ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)</article-title>. <source>Eur J Heart Fail</source> <year>2008</year>; <volume>10</volume>(<issue>10</issue>): <fpage>933</fpage>–<lpage>989</lpage>.</citation>
</ref>
<ref id="bibr53-1474515112443439">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Frattini</surname><given-names>E</given-names></name>
<name><surname>Lindsay</surname><given-names>P</given-names></name>
<name><surname>Kerr</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>Learning needs of congestive heart failure patients</article-title>. <source>Prog Cardiovasc Nurs</source> <year>1998</year>; <volume>13</volume>(<issue>2</issue>): <fpage>11</fpage>–<lpage>16</lpage>, <fpage>33</fpage>.</citation>
</ref>
<ref id="bibr54-1474515112443439">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hagenhoff</surname><given-names>BD</given-names></name>
<name><surname>Feutz</surname><given-names>C</given-names></name>
<name><surname>Conn</surname><given-names>VS</given-names></name><etal/>
</person-group>. <article-title>Patient education needs as reported by congestive heart failure patients and their nurses</article-title>. <source>J Adv Nurs</source> <year>1994</year>; <volume>19</volume>(<issue>4</issue>): <fpage>685</fpage>–<lpage>690</lpage>.</citation>
</ref>
<ref id="bibr55-1474515112443439">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Avila-Funes</surname><given-names>JA</given-names></name>
<name><surname>Gray-Donald</surname><given-names>K</given-names></name>
<name><surname>Payette</surname><given-names>H</given-names></name>
</person-group>. <article-title>Association of nutritional risk and depressive symptoms with physical performance in the elderly: the Quebec longitudinal study of nutrition as a determinant of successful aging (NuAge)</article-title>. <source>J Am Coll Nutr</source> <year>2008</year>; <volume>27</volume>(<issue>4</issue>): <fpage>492</fpage>–<lpage>498</lpage>.</citation>
</ref>
<ref id="bibr56-1474515112443439">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lourenco</surname><given-names>BH</given-names></name>
<name><surname>Vieira</surname><given-names>LP</given-names></name>
<name><surname>Macedo</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Nutritional status and adequacy of energy and nutrient intakes among heart failure patients</article-title>. <source>Arq Bras Cardiol</source> <year>2009</year>; <volume>93</volume>(<issue>5</issue>): <fpage>541</fpage>–<lpage>548</lpage>.</citation>
</ref>
<ref id="bibr57-1474515112443439">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lemon</surname><given-names>SC</given-names></name>
<name><surname>Olendzki</surname><given-names>B</given-names></name>
<name><surname>Magner</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>The dietary quality of persons with heart failure in NHANES 1999–2006</article-title>. <source>J Gen Intern Med</source> <year>2010</year>; <volume>25</volume>(<issue>2</issue>): <fpage>135</fpage>–<lpage>140</lpage>.</citation>
</ref>
<ref id="bibr58-1474515112443439">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arcand</surname><given-names>J</given-names></name>
<name><surname>Floras</surname><given-names>V</given-names></name>
<name><surname>Ahmed</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Nutritional inadequacies in patients with stable heart failure</article-title>. <source>J Am Diet Assoc</source> <year>2009</year>; <volume>109</volume>(<issue>11</issue>): <fpage>1909</fpage>–<lpage>1913</lpage>.</citation>
</ref>
<ref id="bibr59-1474515112443439">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>von Haehling</surname><given-names>S</given-names></name>
<name><surname>Lainscak</surname><given-names>M</given-names></name>
<name><surname>Springer</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Cardiac cachexia: a systematic overview</article-title>. <source>Pharmacol Ther</source> <year>2009</year>; <volume>121</volume>(<issue>3</issue>): <fpage>227</fpage>–<lpage>252</lpage>.</citation>
</ref>
<ref id="bibr60-1474515112443439">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Freeman</surname><given-names>LM</given-names></name>
</person-group>. <article-title>The pathophysiology of cardiac cachexia</article-title>. <source>Curr Opin Support Palliat Care</source> <year>2009</year>; <volume>3</volume>(<issue>4</issue>): <fpage>276</fpage>–<lpage>281</lpage>.</citation>
</ref>
<ref id="bibr61-1474515112443439">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Catapano</surname><given-names>G</given-names></name>
<name><surname>Pedone</surname><given-names>C</given-names></name>
<name><surname>Nunziata</surname><given-names>E</given-names></name><etal/>
</person-group>. <article-title>Nutrient intake and serum cytokine pattern in elderly people with heart failure</article-title>. <source>Eur J Heart Fail</source> <year>2008</year>; <volume>10</volume>(<issue>4</issue>): <fpage>428</fpage>–<lpage>434</lpage>.</citation>
</ref>
<ref id="bibr62-1474515112443439">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>German</surname><given-names>L</given-names></name>
<name><surname>Feldblum</surname><given-names>I</given-names></name>
<name><surname>Bilenko</surname><given-names>N</given-names></name><etal/>
</person-group>. <article-title>Depressive symptoms and risk for malnutrition among hospitalized elderly people</article-title>. <source>J Nutr Health Aging</source> <year>2008</year>; <volume>12</volume>(<issue>5</issue>): <fpage>313</fpage>–<lpage>318</lpage>.</citation>
</ref>
<ref id="bibr63-1474515112443439">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martin</surname><given-names>CT</given-names></name>
<name><surname>Kayser-Jones</surname><given-names>J</given-names></name>
<name><surname>Stotts</surname><given-names>NA</given-names></name><etal/>
</person-group>. <article-title>Risk for low weight in community-dwelling, older adults</article-title>. <source>Clin Nurse Spec</source> <year>2007</year>; <volume>21</volume>(<issue>4</issue>): <fpage>203</fpage>–<lpage>211</lpage>; quiz 12–13.</citation>
</ref>
<ref id="bibr64-1474515112443439">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grossniklaus</surname><given-names>DA</given-names></name>
<name><surname>Dunbar</surname><given-names>SB</given-names></name>
<name><surname>Tohill</surname><given-names>BC</given-names></name><etal/>
</person-group>. <article-title>Psychological factors are important correlates of dietary pattern in overweight adults</article-title>. <source>J Cardiovasc Nurs</source> <year>2010</year>; <volume>25</volume>(<issue>6</issue>): <fpage>450</fpage>–<lpage>460</lpage>.</citation>
</ref>
<ref id="bibr65-1474515112443439">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Song</surname><given-names>EK</given-names></name>
<name><surname>Moser</surname><given-names>DK</given-names></name>
<name><surname>Payne-Emerson</surname><given-names>H</given-names></name><etal/>
</person-group>. <article-title>Depressive symptoms, poor nutritional intake and event-free survival in patients with heart failure: a deadly chain of events</article-title>. <source>J Card Fail</source> <year>2009</year>; <volume>15</volume>(<issue>65</issue>): <fpage>S5</fpage>–<lpage>S6</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>